COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article Access statistics

Viewed: 493

Emailed: 0

PDF Downloaded: 186

Journal of Pharmaceutical and Biological Sciences

Cost variation analysis among different antidepressant drugs used to treat major depressive disorder

Full Text PDF Share on Facebook Share on Twitter

Author Details : Raman K. Tripathi, Shamsher Singh

Volume : 6, Issue : 2, Year : 2018

Article Page : 51-54

Suggest article by email


The Indian pharmaceutical industry produces drugs on a large scale and standing on 3rd rank bases on the scale of production. Due to this huge scale of production they produce all of the drugs and there are many brands of the same drugs. These brands are having competition between them so cost variation could be seen.
Aim:The aim of our study is to find out the cost variation among the antidepressant drugs used in the treatment of major depressive disorder (MDD) that are the tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), the serotonin–norepinephrine reuptake inhibitors (SNRIs).
Materials and Method:The anti-depressant drugs that are manufactured by various Indian pharmaceutical industries are analyzed in that study. The data was collected by the authors from “Current Index of Medical Specialties” (CIMS) online edition, and Mobile Application of National Pharma Pricing.
Results:There are 15 anti-depressant drugs with 63 formulations are available in the marked of India with 1173 brands. Among all the antidepressant drugs, the highest cost ratio and percentage cost variation was found for the fluvoxamine 100 mg followed by amitriptyline 50 mg Nortriptyline 20 mg and clomipramine 75 mg. The highest numbers of brands are for escitalopram 10 mg followed by Sertraline 50 mg and Paroxetine 37.5 mg.
Conclusion:It is concluded that there is very high cost variation among the marked preparations of antidepressant drugs used to treat Major depressive disorder (MDD).

Keywords: Major Depressive Disorder (MDD), Tricyclic antidepressants (TCAs), Selective serotonin reuptake inhibitors (SSRIs), Monoamine oxidase inhibitors (MAOIs), The serotonin–norepinephrine reuptake inhibitors (SNRIs), Cost ratio, Percentage cost variation

Doi : 10.18231/2320-1924.2018.0010

How to cite : Tripathi R K, Singh S, Cost variation analysis among different antidepressant drugs used to treat major depressive disorder. J Pharm Biol Sci 2018;6(2):51-54

Copyright © 2018 by author(s) and J Pharm Biol Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (